Hosted by RSNA · EN
Dr. Yashbir Singh speaks with Dr. Ashok Srinivasan about his journey in neuroradiology, the hallmarks of impactful imaging research, and how mentorship and focused clinical questions drive meaningful scientific advances. Dr. Srinivasan also shares expert insights on translating AI and advanced imaging techniques into real-world practice, emphasizing clinical value, standardization, and patient-centered outcomes. Radiology: Imaging Cancer
Dr. Yashbir Singh sits down with Dr. Lacey McNally to explore her groundbreaking work advancing contrast agents, molecular imaging, and first‑in‑human clinical trials. Together, they discuss the challenges of translational research, the essentials of high‑quality imaging manuscripts, and the evolving landscape of scientific publishing. Radiology: Imaging Cancer
Dr. Yash Singh sits down with Dr. Sudhakar Venkatesh to explore his global journey in radiology and how innovations like MR elastography are transforming the noninvasive diagnosis and staging of liver disease. They discuss the future of quantitative, AI-enhanced imaging in detecting liver cancer and biliary diseases earlier—shifting radiology from passive observation to a central, collaborative force in precision medicine. Radiology: Imaging Cancer special collection for Pancreatic Adenocarcinoma, Pancreatic Neuroendocrine, and Hepatobiliary Cancers.
In this episode, Tom DeSilvio, Brennan Flannery, and Yash Singh reflect on their experiences as trainee editorial board members, discussing what they've learned about peer review, clinical relevance, and evaluating innovation in cancer imaging research. They also share highlights from attending RSNA in person, including emerging trends like AI integration, foundation models, and the value of community and collaboration in radiology. Radiology: Imaging Cancer
Brennan Flannery and Thomas DeSilvio sit down with Pallavi Tiwari to explore how AI is transforming medical imaging toward more individualized and precise care. The conversation dives into imaging the individual, trust in AI systems, and what the future holds for translating advanced models into real-world clinical impact. Radiology: Imaging Cancer
Dr. Yashbir Singh talks with Dr. Bonnie Joe about her journey from engineering to breast imaging and how a systematic, analytical approach shapes her clinical practice. Dr. Joe shares insights on breast screening guidelines, dense breast management, health equity, and how AI could help close gaps in access to care. Radiology: Imaging Cancer R&E Foundation
Drs. Ghazal Zandieh, Yash Singh, Thomas DeSilvio, and Brennan Flannery speak with Dr. Joseph Ippolito about how metabolic imaging is transforming cancer diagnosis and treatment through advanced PET and MRI techniques. Together they explore how personalized medicine and sex-specific metabolic differences are reshaping the way radiologists understand and treat glioblastoma. Radiology: Imaging Cancer Journal
In this episode, we begin with a brief introduction of our podcasters, Tom DeSilvio, Brennan Flannery, Yash Singh, and Ghazal Zandieh, before welcoming Dr. Gary Luker, Editor‑in‑Chief of the RSNA journal, Radiology: Imaging Cancer. Our goal is to showcase and better introduce the journal while highlighting the future of individualized cancer imaging. Dr. Luker joins us to discuss how advanced imaging, artificial intelligence, and translational research are transforming personalized cancer care. Radiology: Imaging Cancer Journal
Dr. Brandon K.K. Fields speaks with Dr. Jennifer Holter-Chakrabarty about her groundbreaking research on fluorine-18 fluorothymidine (FLT) PET in the imaging of gastrointestinal graft-versus-host disease (GVHD) after allogeneic stem cell transplantation. Together, they explore a potential future role for FLT-PET in detection of early and/or subclinical GVHD, which may serve to guide future treatment strategies for transplant patients in years to come. 18F-FLT PET and Blood-based Biomarkers for IdentifyingGastrointestinal Graft versus Host Disease after Allogeneic CellTransplantation. Holter-Chakrabarty and McNally et al. Radiology: Imaging Cancer 2025; 7(1):e240096.
Dr. Lauren Burkard-Mandel discusses the importance of breast cancer screening at age 40 with guest Dr. Debra Monticciolo. They explore the 2023 U.S. Preventive Services Task Force's draft statement advocating for the initiation of biennial mammograms at age 40, down from the previous age of 50. Tune in for an insightful discussion that could impact women's health decisions for years to come! Articles discussed: https://doi.org/10.1093/jbi/wbad103 https://doi.org/10.1002/cncr.33846